Molecular mechanisms related to occult hepatitis B virus (HBV) infection, particularly those based on genotype C infection, have rarely been determined thus far in the ongoing efforts to determine infection mechanisms. Therefore, we aim to elucidate the mutation patterns in the surface open reading frame (S ORF) underlying occult infections of HBV genotype C in the present study. Nested PCRs were applied to 624 HBV surface antigen (HBsAg) negative Korean subjects. Cloning and sequencing of the S ORF gene was applied to 41 occult cases and 40 control chronic carriers. Forty-one (6.6%) of the 624 Korean adults with HBsAg-negative serostatus were found to be positive for DNA according to nested PCR tests. Mutation frequencies in the three regions labeled here as preS1, preS2, and S were significantly higher in the occult subjects compared to the carriers in all cases. A total of two types of deletions, preS1 deletions in the start codon and preS2 deletions as well as nine types of point mutations were significantly implicated in the occult infection cases. Mutations within the “a” determinant region in HBsAg were found more frequently in the occult subjects than in the carriers. Mutations leading to premature termination of S ORF were found in 16 occult subjects (39.0%) but only in one subject from among the carriers (2.5%). In conclusion, our data suggest that preS deletions, the premature termination of S ORF, and “a” determinant mutations are associated with occult infections of HBV genotype C among a HBsAg-negative population. The novel mutation patterns related to occult infection introduced in the present study can help to broaden our understanding of HBV occult infections.
References
[1]
Lee WM (1997) Medical progress - Hepatitis B virus infection. New England Journal of Medicine 337: 1733–1745.
[2]
Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet Infectious Diseases 2: 395–403.
[3]
Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR (2002) Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. Journal of Korean Medical Science 17: 457–462.
[4]
Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, et al. (2001) A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology. 33: 218–223.
[5]
Kim H, Jee YM, Song BC, Shin JW, Yang SH, et al. (2007) Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 50: 52–57.
[6]
Kim HJ, Park JH, Jee Y, Lee SA, Kim H, et al. (2008) Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. Journal of Medical Virology 80: 1337–1343.
[7]
Mun HS, Lee SA, Jee Y, Kim H, Park JH, et al. (2008) The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. Journal of Medical Virology. 80: 1189–1194.
[8]
Mun HS, Lee SA, Kim H, Hwang ES, Kook YH, et al. (2011) Novel F141L Pre-S2 Mutation in Hepatitis B Virus Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Genotype C Infections. Journal of Virology 85: 123–132.
[9]
Song BC, Kim SH, Kim H, Ying YH, Kim HJ, et al. (2005) Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. Journal of Medical Virology 76: 194–202.
[10]
Conjeevaram H, Lok AS (2001) Occult hepatitis B virus infection: A hidden menace? Hepatology 34: 204–206.
[11]
Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. Journal of Hepatology 46: 160–170.
[12]
Torbenson M, Thomas DL (2002) Occult hepatitis B. Lancet Infectious Diseases. 2: 479–486.
[13]
Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, et al. (1998) Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. Journal of Medical Virology 54: 249–255.
[14]
Liang TJ, Baruch Y, Benporath E, Enat R, Bassan L, et al. (1991) Hepatitis-B Virus-Infection in Patients with Idiopathic Liver-Disease. Hepatology 13: 1044–1051.
[15]
Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E (1993) Hepatitis-B Virus-DNA in Serum and Liver Is Commonly Found in Chinese Patients with Chronic Liver-Disease Despite the Presence of Antibodies to HBsAg. Hepatology 17: 538–544.
[16]
Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, et al. (1981) State of Hepatitis-B Virus-DNA in Hepatocytes of Patients with Hepatitis-B Surface Antigen-Positive and Antigen-Negative Liver-Diseases. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 78: 3906–3910.
[17]
Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981) Integration of Hepatitis-B Virus-DNA into the Genome of Liver-Cells in Chronic Liver-Disease and Hepatocellular-Carcinoma - Studies in Percutaneous Liver Biopsies and Postmortem Tissue Specimens. New England Journal of Medicine 305: 1067–1073.
[18]
Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, et al. (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology 34: 447–454.
[19]
De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, et al. (2000) The impact of previous HBV infection on the course of chronic hepatitis C. American Journal of Gastroenterology. 95: 3529–3536.
[20]
Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, et al. (2001) HCV genotype and “silent” HBV coinfection: Two main risk factors for a more severe liver disease. Journal of Medical Virology 64: 350–355.
[21]
Yao JDC, Beld MGHM, Oon LLE, Sherlock CH, Germer J, et al. (2003) Multi-center evaluation of the Versant (R) HBV DNA 3.0 assay: Assessment of analytical and clinical performance. Hepatology 38: 718a–718a.
[22]
Saitou N, Nei M (1987) The Neighbor-Joining Method - a New Method for Reconstructing Phylogenetic Trees. Molecular Biology and Evolution 4: 406–425.
[23]
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Molecular Biology and Evolution 24: 1596–1599.
[24]
Felsenstein J (1985) Confidence-Limits on Phylogenies - an Approach Using the Bootstrap. Evolution 39: 783–791.
[25]
Lee SA, Kim K, Kim H, Kim BJ (2012) Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases. Journal of Hepatology 56: 63–69.
[26]
Bruss V (2002) Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36: 1327–1329.
[27]
Park NH, Chung YH, Lee HS (2010) Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period. Intervirology 53: 20–28.
[28]
Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, et al. (2000) Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology 15: 1356–1361.
[29]
Cooreman MP, Leroux-Roels G, Paulij WP (2001) Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. Journal of Biomedical Science 8: 237–247.
[30]
Hunt CM, McGill JM, Allen MI, Condreay LD (2000) Clinical relevance of hepatitis B viral mutations. Hepatology 31: 1037–1044.
[31]
Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, et al. (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023–2032.
[32]
Wang HC, Huang WY, Lai MD, Su IJ (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Science 97: 683–688.
[33]
Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology 127: S56–S61.
[34]
Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127: S35–S50.
[35]
Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, et al. (2002) Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35: 1215–1224.
[36]
Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, et al. (2007) Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45: 277–285.
[37]
Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F (2010) Differential Impact of Immune Escape Mutations G145R and P120T on the Replication of Lamivudine-Resistant Hepatitis B Virus e Antigen-Positive and -Negative Strains. Journal of Virology 84: 1026–1033.
[38]
Lada O, Benhamou Y, Poynard T, Thibault V (2006) Coexistence of hepatitis B surface antigen (HBs Ag) and Anti-HBs antibodies in chronic hepatitis-B virus carriers: Influence of “a” determinant variants. Journal of Virology 80: 2968–2975.
[39]
Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya PB, et al. (2007) Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. Journal of Clinical Virology 40: 312–317.
[40]
Mu SC, Lin YM, Jow GM, Chen BF (2009) Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. Journal of Hepatology 50: 264–272.
[41]
Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter. Gastroenterology 127: 1356–1371.
